The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.54BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Trailing P/E
24.15x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Revenue (TTM)
5.55BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Profit Margin
4.85%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Beta
-0.1330x
vs all stocks
Updated Sep 28, 2026
52-Week Change
198.85%
vs all stocks
Updated Sep 28, 2026
Market Capitalization
6.54BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Enterprise Value
9.78BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Trailing P/E
24.15x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Forward P/E
15.22x
vs Medical Care Facilities peers
Updated Sep 28, 2026
PEG Ratio
0.5313x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Price to Sales (TTM)
1.18x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Price to Book (MRQ)
5.89x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Enterprise to Revenue
1.76x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Enterprise to EBITDA
20.46x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Gross Margin
17.07%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Profit Margin
4.85%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Operating Margin
7.66%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Return on Assets (TTM)
4.60%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Return on Equity (TTM)
27.92%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Revenue (TTM)
5.55BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Revenue per Share (TTM)
35.34USDUpdated Sep 28, 2026
Quarterly Revenue Growth
9.10%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Gross Profit (TTM)
961.21MUSD
vs all stocks (USD)
Updated Sep 28, 2026
EBITDA (TTM)
480.23MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Net Income (TTM)
269.17MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Quarterly Earnings Growth (YoY)
49.90%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Operating Cash Flow (TTM)
573.25MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Levered Free Cash Flow (TTM)
378.32MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Sep 28, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Sep 28, 2026
Minority Interest (Equity)
5.68MUSDFY2025 · Dec 31, 2025
Revenue
5.29BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
4.51BUSDFY2025 · Dec 31, 2025
Gross Profit
780.33MUSDFY2025 · Dec 31, 2025
Operating Income
309.60MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
284.45MUSDFY2025 · Dec 31, 2025
Income Tax Expense
92.99MUSDFY2025 · Dec 31, 2025
Net Income
191.46MUSDFY2025 · Dec 31, 2025
EBIT
312.81MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
368.48MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
415.07MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
28.36MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.23USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.22USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
156.18MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
156.18MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
191.46MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
82.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
343.04MUSDFY2025 · Dec 31, 2025
Free Cash Flow
93.89MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
232.05MUSDFY2025 · Dec 31, 2025
Income Tax Paid
84.05MUSDFY2025 · Dec 31, 2025
Interest Paid
40.51MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
191.46MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
55.66MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-17.73MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
54.07MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
52.17MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
14.43MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
14.86MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-21.88MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-249.16MUSDFY2025 · Dec 31, 2025
Net Acquisitions
0.00USDFY2025 · Dec 31, 2025
Purchase of Investments
-21.21MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
750.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-269.62MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-60.22MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-8.77MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-68.99MUSDFY2025 · Dec 31, 2025
Shares Outstanding
158.34MSharesUpdated Sep 28, 2026
Float Shares
48.84MSharesUpdated Sep 28, 2026
Shares Short
3.74MSharesUpdated Sep 28, 2026
Short Ratio
5.66days
vs all stocks
Updated Sep 28, 2026
Short % of Shares Outstanding
7.74%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 2.36%.Updated Sep 28, 2026
% Held by Insiders
69.10%
vs all stocks
Updated Sep 28, 2026
% Held by Institutions
31.61%
vs all stocks
Updated Sep 28, 2026
Total Cash (MRQ)
164.45MUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Cash per Share (MRQ)
1.04USDUpdated Sep 28, 2026
Total Debt (MRQ)
3.40BUSD
vs all stocks (USD)
Updated Sep 28, 2026
Total Debt to Equity (MRQ)
3.05x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Current Ratio (MRQ)
0.9120x
vs Medical Care Facilities peers
Updated Sep 28, 2026
Book Value per Share (MRQ)
7.01USDUpdated Sep 28, 2026
Total Assets
5.58BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.07BUSDFY2025 · Dec 31, 2025
Total Liabilities
4.63BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
4.51BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
3.63BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.00BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
197.02MUSDFY2025 · Dec 31, 2025
Accounts Receivable
628.13MUSDFY2025 · Dec 31, 2025
Accounts Payable
192.23MUSDFY2025 · Dec 31, 2025
Short-term Debt
186.46MUSDFY2025 · Dec 31, 2025
Long-term Debt
3.28BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
152.94MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
157.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
309.58MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
952.45MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
10.31USDUpdated Sep 28, 2026
52-Week High
49.49USDUpdated Sep 28, 2026
52-Week Change
198.85%
vs all stocks
Updated Sep 28, 2026
Beta
-0.1330x
vs all stocks
Updated Sep 28, 2026
50-Day MA
44.33USDUpdated Sep 28, 2026
200-Day MA
38.74USDUpdated Sep 28, 2026
Avg 10-Day Volume
795.30KSharesUpdated Sep 28, 2026
Avg 30-Day Volume
691.63KSharesUpdated Sep 28, 2026
Diluted EPS (TTM)
1.71USDUpdated Sep 28, 2026
Other Income / Expense
3.22MUSDFY2025 · Dec 31, 2025
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its return on equity is high for the gross margin it earns, with revenue up three years and profit in all five.
Reads
Is this company growing?
Growth With Volume Backing
Revenue and net income have compounded over six years, and volume has leaned up with it.
Reads
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.07: grey zoneSignificant
Altman Z-Score: 2.07
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $6.54B, above the global median of $1.18BNotable
Market cap (USD): 6,536,649,128Global Median: 1,180,223,658.953
Revenue is $5.55B, above the global median of $548.88MNotable